Scholar Rock Holding (SRRK) Interest Expenses (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Interest Expenses came in at $2.4 million in Q1 2026, up 15.46% year-on-year from $2.1 million in Q1 2025, and up 112.57% quarter-over-quarter from $1.1 million in Q4 2025.

Scholar Rock Holding (SRRK) Interest Expenses (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Interest Expenses history runs 10 years deep, the most recent figure standing at $2.4 million for Q1 2026.

  • On a quarterly basis, Interest Expenses rose 15.46% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $8.4 million, a 1.13% increase from a year earlier, with the FY2025 full-year figure at $185.5 million, down 36.69% from the prior year.
  • Interest Expenses grew to $2.4 million in Q1 2026 per SRRK's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $159.6 million in Q3 2025 and bottomed at $748000.0 in Q2 2022.
  • The 5-year median for Interest Expenses is $2.4 million (2026), against an average of $20.5 million.
  • Across the five-year window, Interest Expenses tumbled 98.4% in 2022 and soared 5280.62% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at $1.3 million in 2022, then advanced by 23.58% to $1.7 million in 2023, then soared by 72.71% to $2.9 million in 2024, then sank by 61.05% to $1.1 million in 2025, then soared by 112.57% to $2.4 million in 2026.
  • Per Business Quant, the three latest SRRK Interest Expenses figures stand at $2.4 million (Q1 2026), $1.1 million (Q4 2025), and $159.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Scholar Rock Holding 6.10 Bn 6.10 Bn - 2.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.37 Mn
Mar 31, 2026 2.37 Mn
Dec 31, 2025 1.11 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 159.64 Mn
Sep 30, 2025 159.64 Mn
Jun 30, 2025 155.14 Mn
Jun 30, 2025 155.14 Mn
Mar 31, 2025 2.05 Mn
Mar 31, 2025 2.05 Mn
Dec 31, 2024 2.86 Mn
Dec 31, 2024 2.86 Mn
Sep 30, 2024 2.97 Mn
Sep 30, 2024 2.97 Mn
Jun 30, 2024 3.53 Mn
Jun 30, 2024 3.53 Mn
Mar 31, 2024 1.73 Mn
Mar 31, 2024 1.73 Mn
Dec 31, 2023 1.66 Mn
Dec 31, 2023 1.66 Mn